Faculty

Register

Ophthalmology Co-Chairs

Andrea Kossler, MD, FACS

Byers Eye Institute, Stanford School of Medicine Stanford, CA

Andrea Lora Kossler, MD, is Assistant Professor of Ophthalmology at Stanford University School of Medicine and Director of the Ophthalmic Plastic, Reconstructive Surgery and Orbital Oncology Service at the Byers Eye Institute at Stanford. She specializes in plastic and reconstructive surgery of the forehead, mid-face, and eyes and has a special interest in aesthetic medicine and thyroid eye disease. Andrea has been in practice for over 8 years and treats adults and children with oculoplastic conditions. Dr. Kossler’s research interests include thyroid eye disease, orbital oncology, and neurostimulation for ocular surface disease.

Andrea is the Co-Director of the Thyroid Eye Disease Center at Stanford Hospital Center where she works together with a multidisciplinary team including an endocrinologist and radiation oncologist to provide patient centered care to patients diagnosed with thyroid eye disease. She is also the Director of the Stanford Aesthetic Eye Surgery Center where she specializes in cosmetic surgery and aesthetic treatments of the eyelids and face.

She earned her medical degree from Georgetown University School of Medicine where she graduated summa cum laude and valedictorian of her class. She holds a Bachelor of Science degree from the University of Florida where she graduated with highest honors. She completed her internship in internal medicine at the Mount Sinai Medical Center and her residency in Ophthalmology at the number one ranked Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. She continued at the Bascom Palmer Eye Institute to complete a fellowship in Ophthalmic Plastic and Reconstructive surgery and served as a Clinic Instructor of Ophthalmology.

Outside of work Andrea enjoys time with her husband, two daughters and dog Roxy.

Michael Kazim MD, FACS

Harkness Eye Institute, Columbia University Medical Center New York, NY

Dr. Kazim is Clinical Professor of Ophthalmology and Surgery at the Harkness Eye Institute – Columbia University Medical Center.  He completed medical school, an internship in General Surgery and residency in Ophthalmology at Columbia before moving to University of Pennsylvania- Scheie Eye Institute/Children’s Hospital of Philadelphia for fellowship training in Oculoplastic Surgery and Craniofacial Ophthalmology.  He then took a second fellowship in Pittsburgh in Orbital Surgery and Neuro-ophthalmology.  He subsequently returned to the Harkness Eye Institute where he has practiced since 1990.  Dr Kazim is world recognized for his work in the field of orbital disease including the management of complex orbital tumors and Thyroid Eye Disease.  He is a member of the International Orbit Society, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), American Academy of Ophthalmology (AAO), American College of Surgeons and is a founding member and first President of the International Thyroid Eye Disease Society (ITEDS).  ITEDS fosters clinical research and patient education in he field of Thyroid Eye Disease.  He has published 200 article and book chapters, and is an editor or reviewer for a dozen peer-review journals.  His clinical interests have fostered the development of multiple new surgical procedures and devices.  He annually trains ASOPRS national and international fellows as well as twelve Columbia ophthalmology residents and medical students.  He has earned the Departmental Teaching award on two occasions, AAO teaching recognition, and has been invited to speak at over 200 national and international conferences, universities and hospitals.

Endocrinology Co-Chairs

Chrysoula Dosiou, MD, MS

Division of Endocrinology, Stanford School of Medicine Stanford, CA

Dr. Dosiou specializes in the treatment of patients with thyroid disease. She has a special interest in the evaluation and treatment of thyroid disease in the setting of pregnancy and the care of patients with thyroid-eye disease.

Marius Stan, MD

Division of Endocrinology, Mayo Clinic Rochester, MN

Marius N. Stan, M.D., is a consultant in endocrinology at Mayo Clinic in Rochester, MN since 2007. He completed his endocrinology fellowship at Mayo Clinic Rochester and then obtained a Master degree in Clinical and Translational Research from Mayo Graduate School. He is Associate Professor in Medicine and is the current Chair of the Thyroid Core Group for the Division of Endocrinology at Mayo Clinic. He combines clinical work with clinical research. He is primarily working in the area of autoimmune thyroid diseases, with a specific interest in Graves’ disease, Thyroid Eye Disease (TED) and Pretibial Dermopathy. He has been the PI or Co-investigator for a number of clinical trials targeting these disorders. He is a member of the ATA Taskforce focusing on the evaluation and management of hyperthyroidism. The second main area of research relates to management of thyroid nodules through radiofrequency ablation (RFA). This involves benign toxic and non-toxic nodules as well as thyroid carcinoma. Dr. Stan’s research aims to identify novel disease prognostic markers as well as new therapies for these conditions.

 

________________________

Confirmed Faculty and Speakers

 

Prof. Lelio Baldeschi MD, PhD, FEBO, Hon. FAPSOPRS

Catholic University of Louvain Bruxelles, Belgium

Afterwards he has been a Universitary Docent (UD), Consultant surgeon and Head to Orbital Centre, University of Amsterdam, where he trained in oculoplastic, lacrimal and orbital surgery medical students, residents in ophthalmology, nineteen international fellows, and had the opportunity to publish in the field of orbital and adnexal diseases. At present he is “Chef de Clinique” and Clinical Professor to the Department of Ophthalmology , Catholic University of Louvain, at the Saint Luc Hospital of Bruxelles. He has been member of the scientific advisory board, invited speaker and faculty member at a wide variety of international congresses, and courses. He is active reviewer and/or member of the editorial board of ophthalmic, maxillofacial, plastic surgery, and internal medicine journals, visiting professor to several European, North American and Asian universities, and had organised national and international congresses.

Currently he is member of the Italian Society of Ophthalmology, European Society of Ophthalmic Plastic and Reconstructive Surgery, has been elected honorary members of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery, serve in the steering committee of the European Group on Graves’ Orbitopathy, is for the second term the President of the Italian Society of Ophthalmic Plastic Surgery, is the Secretary and the Elected President of the International Society of Dacryology and Dry Eye.

Tomasz Bednarczuk, MD, PhD

Medical University of Warsaw Warsaw, Poland
Tomasz Bednarczuk, M.D, Ph.D., professor of medicine, at the Medical University of Warsaw. 
Dr Bednarczuk completed his internal medicine and endocrinology training in Warsaw and spent 3 years at the
Thyroid Eye Disease Laboratory, Allegheny-Singer Research Institute, Pittsburgh, USA (supervisor – Prof. Jack Wall)  and Division of Endocrinology and Metabolism, University School of Medicine, Kurume, Japan (supervisor – Prof. Yuji Hiromatsu). He received his Ph.D. in 1998 and his habilitation degree in 2004  from the Medical Research Center, Polish Academy of Science.
Dr Bednarczuk is a clinical scientist with a special research
focus on the pathogenesis of Graves’ orbitopathy and the genetics of Graves’ disease. Dr Bednarczuk serves as Treasurer of the European Thyroid Association.

César A. Briceño, MD

Perelman School of Medicine Philadelphia, PA

Dr. César A. Briceño is an Associate Professor of Clinical Ophthalmology at the University of Pennsylvania. He completed his undergraduate studies at Harvard University and his medical degree at Johns Hopkins University, followed by residency training at the University of Southern California and fellowship training in oculoplastics at the University of Michigan. He serves as Assistant Dean of Diversity and Cultural Affairs and Advisory Dean at the Perelman School of Medicine, as well as Medical Director of the Scheie Eye Institute at the Penn Presbyterian Medical Center, where he co-directs the Thyroid Eye Disease (TED) program.

Wiley Chambers, MD

Food and Drug Administration Silver Spring, MD

Wiley A. Chambers, MD, was a Supervisory Medical Officer in the Office of New Drugs, Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). After receiving an undergraduate degree from Colgate University, Dr. Chambers completed medical school and a residency in Ophthalmology at The George Washington University School of Medicine and Health Sciences in Washington, DC. He is currently a Clinical Professor of Ophthalmology and Adjunct Assistant Professor of Computer Medicine at The George Washington University. He joined the FDA in 1987, as a primary reviewer for ophthalmic drug products and in 1990 became a Supervisory Medical Officer for Ophthalmologic Drug Products. In this capacity, Dr. Chambers has supervisory responsibility for the clinical review of ophthalmologic drug products and ophthalmic therapeutic biologic products submitted to the Center for Drug Evaluation and Research. Additionally, Dr. Chambers is the recipient of numerous Public Health Service, FDA and Center for Drug Evaluation and Research awards for his work with the FDA and he has served as the American Academy of Ophthalmology’s Delegate to past United States Pharmacopeia Conventions.

Raymond Cho, MD

Ohio State University Wexner Medical Center Westerville, OH

As an oculoplastic surgeon, I specialize in plastic and reconstructive surgery of the eyelids, eye socket and tear drainage system. Vision is a vital sensory function and the appearance of the eyes profoundly affects how people view themselves. When impaired by trauma, cancer, or the ravages of time, my job is to restore these critical aspects of a patient’s life.

My approach to care is to build partnerships with my patients, educate them about their diseases and offer various treatment options. I guide them through the treatment process to ensure they receive the highest level of care. Patients know themselves best, and given the right information, can make the best choices for themselves.

I’m proud to be part of The Ohio State University Wexner Medical Center. Not only do I get to care for wonderful and interesting patients, but I also have the opportunity to pass my knowledge and expertise on to the next generation of physicians.

I grew up in Toledo, Ohio and then traveled the world for 21 years as an Army physician before retiring from the military and moving back to the Buckeye State with my wife and two boys. When I’m not working, I enjoy spending time with my family, watching Ohio State football and singing with the Columbus Symphony Chorus.

Kimberly Cockerham, MD, FACS

Oculoplastic Eyelid Rejuvenation and Reconstruction Specialist Neuro-Ophthalmology, Orbital Disease, Adult Strabismus and Eyelid Reconstruction San Diego, CA

I was raised in San Mateo, California and earned an undergraduate degree in Biology at UC San Diego, Revelle College. On acceptance to George Washington Medical School in Washington DC, I was awarded a health professional scholarship from the US ARMY.

My time in the military taught me to honor and respect my patients and their families and to understand the larger role physicians can play in a community. I remain very committed (through my foundation Let’s Face It Together) to helping the underinsured and their families rebuild their lives – face first: LFITfoundation.org.

  • Board-Certified by the American Board of Ophthalmology 1993, 2003, 2013 and 2023.
  • Fellowship-trained:
    • Cosmetic, laser and reconstructive surgery of the face, eyelids, and eye muscles.
    • Neuro-ophthalmology and orbital disease.
  • Decorated Veteran: National Service Ribbon, two Superior Unit Awards, Army Commendation Medal, National Defense Service Medal and Meritorious Service Medal. Former Chief of Oculoplastics and Orbital Disease at Walter Reed Army Medical Center.
  • Honored Clinician and Surgeon: Who’s Who in American Women, Lifetime Achievement, Who’s Who in Medicine, Best Doctors in America, former Director of Oculoplastics and Orbital Disease at UCSF with two UCSF Star Awards for Excellence, American Academy of Ophthalmology Achievement Award, Senior Achievement Award, Distinguished Service Award and a Special Recognition Award. Served as Adjunct Clinical Associate Professor, Byers Eye Institute at Stanford University for 15 years.
  • Founder: Let’s Face It Together Foundation that provides medical and surgical care for patients without the financial means to address their facial disfigurement and dysfunction.
  • Researcher: Principal investigator for over two dozen studies. Currently recruiting patients with Thyroid Eye Disease for Phase 1-4 clinical trials. Soon to be launched novel drug delivery system for patients with visual loss due to optic nerve dysfunction.
  • Educator: Trained hundreds of medical students, interns and residents and over 40 clinical and research fellows.

I have had the privilege to care for so many wonderful patients over the years and continue to learn every day from you, through my teaching, mentoring and collaborative research. My team and I look forward to meeting you and helping you achieve your goals.

Francis Creighton, MD

Johns Hopkins Medicine Baltimore, MD

Pete Creighton is a fellowship trained neurotologist and lateral skull base surgeon. His clinical practice specializes in surgical and medical treatment of middle ear, inner ear, skull base and facial nerve disorders. These include skull base tumors, vestibular schwannomas (acoustic neuromas), hearing loss, cholesteatoma, cerebrospinal fluid leaks and eardrum perforations. Treatment specializations include cochlear implantation, stapedectomy, mastoidectomy, and middle fossa and translabyrinthine craniotomies.

His research focuses on the integration of robotic and augmented reality platforms to improve surgical safety and efficiency.

Colin Dayan, MA MBBS, FRCP, PhD

Cardiff University School of Medicine Heath Park Whales, UK

Professor of Clinical Diabetes and Metabolism, Cardiff University School of Medicine.  

Colin Dayan trained in medicine at University College, Oxford, and Guy’s and Charing Cross Hospitals in London, UK before obtaining a PhD in the immunology of Graves’ Disease in Laboratory of Marc Feldmann. He then spent a year as an endocrine fellow at the Massachussetts General Hospital in Boston, USA before completing his specialist training in diabetes and endocrinology as a Lecturer in Bristol. He became a consultant senior lecturer in medicine (diabetes/endocrinology) at the University of Bristol in 1995 and Head of Clinical Research at the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology in Bristol in 2002. In 2010, he was appointed to the Chair of Clinical Diabetes and Metabolism and Head of Section at Cardiff University School of Medicine. He served as Director of the Institute of Molecular and Experimental Medicine in 2011 – 2015.

He has a long established interest in translational research in the immunopathology of type 1 diabetes and is currently conducting early phase clinical trials in the development of antigen specific immunotherapy. His clinical interests in diabetes include management of poor compliance in type 1 diabetes, public health measures in the prevention of type 2 diabetes and models of community care in diabetes. He is the lead for diabetes in the Cardiff whole pancreas transplantation programme and with colleagues leads an All Wales anonymised data linkage programme for monitoring childhood type 1 diabetes. He has been part of 2 major EU FP7 programme grants in type 1 diabetes (and coordinator on one), a member of the Juvenile Diabetes Research Foundation Medical and Scientific Committee and the Welsh Diabetes Research Unit. Prof Dayan currently leads the Clinical Engagement and Training Core of the Diabetes UK funded type 1 diabetes UK immunotherapy Consortium which aims to coordinate and support combined efforts to bring immunotherapy for type 1 diabetes into clinical practice, and is Chair of the Type 1 diabetes national Prevention and Therapies Clinical Studies Group.

He also has research interests in thyroid disease which include thyroid autoimmunity, thyroid hormone replacement and bioavailability, genetic epidemiology as applied to population variation in thyroid hormone bioavailability and thyroid eye disease. He became secretary of the European Thyroid Association in 2013 and chairs the UK Thyroid Eye Disease Amsterdam Implementation Group.

Peter Dolman, MD

The University of British Columbia Vancouver, Canada

Peter Dolman is a clinical professor at the University of British Columbia (UBC) in Vancouver, Canada and is on active staff at five hospitals.  He is the director of ophthalmology fellowship programs at UBC, division head of oculoplastics and orbit, and a past president of the BC Society of Eye Physicians and the Canadian Society of Oculoplastics and Reconstructive Surgeons. He is the past- president of the International Thyroid Eye Disease Society and a member of the Orbit Society, an international consortium of orbit experts.

He has supervised over 45 international oculoplastics fellows, has delivered over 250 invited lectures, and published 25 chapters and over 85 journal articles. He recently co-edited a textbook on diseases of the orbit and ocular adnexa which was published in February, 2017.

He has volunteered as a surgeon or lecturer in over 30 developing nations and has received several departmental research and teaching awards, the ASOPRS research award (2007) and the Queen Elizabeth Gold Medal for community service.

Anja Eckstein, MD

University Clinic Essen Essen, Germany

Victor M. Elner, MD, PhD

University of Michigan Kellogg Eye Center Ann Arbor, MI

James A. Garrity, MD

Mayo Clinic Fergus Falls, MN

James A. Garrity received both a B.S. (Biochemistry) and his M.D.  from the University of Minnesota before pursuing residency training in ophthalmology at the Mayo Clinic and subspecialty training in neuro-ophthalmology/orbital surgery in Pittsburgh with Dr. John Kennerdell.  He joined the Department of Ophthalmology at Mayo Clinic Rochester where he was the Whitney and Betty MacMillan Professor of Ophthalmology before retiring after 35 years on staff.  He is currently working part time at a small community hospital near his retirement home in northern Minnesota. Dr. Garrity twice received the Mayo Foundation Teacher of the Year Award for the Department of Ophthalmology, the Honor Award and Senior Honor Award from the American Academy of Ophthalmology.  He was recognized as the Distinguished Mayo Clinic Clinician in 1999 and later was awarded the George T. Tani, M.D. Humanitarian Award by the Minnesota Academy of Ophthalmology for his volunteer work with the Rochester Salvation Army Clinic. He  has more than 100 publications and is a scientific reviewer for several peer-review journals.

Robert A. Goldberg, MD

Stein Eye Institute Los Angeles, CA

Dr. Goldberg is an internationally recognized surgeon, researcher, and teacher. He has developed many new surgeries which are now taught and practiced internationally, including less invasive treatments for eye and orbit cancers, new surgeries for Thyroid eye disease, new surgical techniques for tearing problems. He has had leadership and Executive positions in the American Society Ophthalmic Plastic Reconstructive Surgery, California Academy of Eye Physicians and Surgeons, American Academy of Cosmetic Surgery.

Natalie Homer, MD

Byers Eye Institute at Stanford Palo Alto, CA

Dr. Homer completed her ophthalmology residency at Harvard Medical School and subsequently received specialty training in plastic and reconstructive surgical procedures of the eyelids, orbit, nasolacrimal system and face through an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)-accredited fellowship at TOC Eye and Face in Austin, TX. She completed an additional fellowship through the American Academy of Cosmetic Surgery, training in procedures including rhytidectomy (facelift), platysmaplasty (necklift), forehead/brow lift, blepharoplasty (upper and lower eyelid lift) and autologous fat transfer. She is board certified through the American Academy of Ophthalmology and the American Board of Facial Cosmetic Surgery. Dr. Homer aims to improve her patients’ ocular health and functioning through oculoplastic surgical procedures and to improve patient confidence through restorative cosmetic surgery.

George Kahaly, MD, PhD

Johannes Gutenberg University (JGU) Medical Center Department of Medicine Mainz, Germany

George J Kahaly, M.D., Ph.D. holds the rank of Professor of Medicine and Endocrinology / Metabolism and is chief physician of the endocrine outpatient clinic at the Johannes Gutenberg University (JGU) Medical Center, Mainz, Germany. Dr. Kahaly chairs the ORPHAN referral expert center for Graves’ orbitopathy and autoimmune polyendocrinopathy.

Dr. Kahaly directs the Molecular Thyroid Research Laboratory and has authored 257 original papers and reviews, covering clinical and experimental aspects of endocrine autoimmunity, immunogenetics of thyroid and polyglandular autoimmunity, as well as cardiovascular involvement of metabolic disorders. Original papers and reviews have been published in the New England Journal of Medicine, Lancet, Jama, Clinical Chemistry, the Journal of Autoimmunity, the Journal of Clinical Endocrinology and Metabolism, the Journal of Nuclear Medicine, Endocrinology, Thyroid, Endocrine Reviews, Nature Reviews and Autoimmunity Reviews (current citation H index 44, 7460 citations).

Dr. Kahaly is the 2019 recipient of the American Association of Clinical Endocrinologists / American College of Endocrinology (AACE/ACE) Endocrinology Award. He also is the 2019 recipient of the British Thyroid Association “George Murray” Lecture. Dr. Kahaly has received several further awards: Research program of the German Endocrine Society (2006 & 2008); Poster prize, German Society of Internal Medicine (2006 & 2008); Poster prize, German Endocrine Society (2009); Investigator Award of the European Thyroid Association (2009); Investigator Award of the German Ophthalmic Society (2011); Best Reviewer Award, European Thyroid Journal (2018); and British Medical Association Medical Book Award (2018).

Dr. Kahaly is Editor of the Journal of Clinical Endocrinology & Metabolism, official Organ of the American Endocrine Society. In the years 2009-2012, Dr. Kahaly served as Associate Editor of the journal Thyroid, official journal of the American Thyroid Association (ATA). Dr. Kahaly is also member of the Editorial Board of the European Thyroid Journal, official journal of the European Thyroid Association (ETA). Further, he is member of the scientific program organizing committee (POC) of the 2020 international thyroid congress, ITC, Xian, China.

Dr. Kahaly served as Treasurer and principle officer of the Executive Committee of the ETA between 2007 and 2016. Since the year 2000, he also served on numerous ATA Committees (Laboratory Services Committee 2018-2022, Public Health 2015-2018, Research 2012-2015, Finance and Audit 2007-2011, as well as Membership and Publication Committees 2000-2006). Further, Dr. Kahaly is the Treasurer of the European Group on Graves’ orbitopathy, official subgroup of the ETA. In the years 2005-2011, he was member of the Executive Committee of the German Thyroid Board.

Alon Kahana MD, PhD

Kahana Oculoplastic & Orbital Surgery Livonia, MI

Dr. Alon Kahana is Professor of Oculoplastic Surgery and Vice Chair for Academic Affairs in the Department of Ophthalmology, Oakland University William Beaumont School of Medicine. An internationally renowned expert in orbital and ophthalmic plastic surgery, Dr. Kahana is a sought-after lecturer and a respected leader of our field. He is a Program Director for an ASOPRS-approved fellowship in oculofacial plastic surgery, and teaches ophthalmology residents from Beaumont, Ascension and Kresge/Wayne State University. In his spare time, Dr. Kahana enjoys family activities with his wife and 4 children, participating in athletic activities (especially golf, tennis, skiing, and jogging), listening to and playing music (guitar, piano and bass), and reading history books and mystery novels.

Dr. Kahana was born in Ramat Gan, Israel, and grew up in Connecticut. He completed his undergraduate studies in Biochemistry at Brandeis University, graduating Summa Cum Laude and with Phi Beta Kappa honors. Dr. Kahana received his MD (with Honors) as well as a PhD in Molecular Genetics and Cell Biology from The University of Chicago Pritzker School of Medicine. He completed his residency in ophthalmology and a prestigious ASOPRS fellowship in oculofacial plastic and reconstructive surgery at the University of Wisconsin under the preceptorship of Dr. Mark Lucarelli. He simultaneously completed a facial cosmetic surgery fellowship under the preceptorship of Dr. Bradley Lemke. Dr. Kahana’s fellowship thesis won the prestigious Marvin Quickert Award from the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS).

In 2007, Dr. Kahana was recruited to the University of Michigan Kellogg Eye Center, where he rose up the ranks to become tenured faculty, with an international reputation in orbital surgery – particularly thyroid eye disease – and pediatric oculoplastics – particularly blepharophimosis and congenital ptosis. He has authored over 80 peer-reviewed publications, multiple book chapters and reviews, and has given >100 lectures throughout the United States and internationally, including several endowed lectures and visiting professorships. In 2020, Dr. Kahana was given the honor of delivering the annual Ralph E. Wesley ASOPRS Foundation Lecture. Dr. Kahana has served in numerous leadership positions, including as President of the North American Society of Academic Orbital Surgeons (NASAOS) and Chair of the Thesis Committee and the Scientific Advisory Committee for ASOPRS. He is also a Program Director for his own ASOPRS fellowship.

Dr. Kahana’s research has been awarded grants from the National Eye Institute of the National Institutes of Health, as well as philanthropic organizations and industry. Dr. Kahana was awarded career development and physician awards from Research to Prevent Blindness, and has run a major prospective clinical trial on the treatment of advanced orbital and periocular basal cell carcinoma. Dr. Kahana is also a noted educator, and has won resident teaching awards at both the University of Michigan and the University of Wisconsin.

Dr. Kahana’s practice covers all aspects of orbital and periocular plastic surgery. While continuing to serve the community as the surgeon of last resort for the most complex orbital blinding disorders and for repairing the most challenging complications, Dr. Kahana is also able to bring his considerable experience to the care of more straight-forward concerns, including eyelid and facial cosmetic surgery.

Dr. Kahana draws patients from throughout Michigan and the greater Midwest, as well as destination patients from throughout the United States. He has a national reach for rare and complex disorders, in particular thyroid eye disease, orbital surgery, congenital ptosis and blepharophimosis. Dr. Kahana performs over 250 orbital surgeries per year, in addition to hundreds of eyelid, lacrimal and facial plastic surgeries.

William R. Katowitz, MD

Children's Hospital of Philadelphia Philadelphia, PA

William R. Katowitz, MD, is an attending surgeon in the Division of Ophthalmology at Children’s Hospital of Philadelphia. He works with children with thyroid conditions, hemangiomas and vascular malformations.

Professor Emerita Marian Ludgate, PhD

Cardiff University School of Medicine Cardiff, United Kingdom

Mark A. Lupo, MD

Thyroid & Endocrine Center of Florida Sarasota, FL

 Dr. Mark A. Lupo is the founder and Medical Director of the Thyroid & Endocrine Center of Florida. Dr. Lupo is board-certified in Endocrinology and Internal Medicine. Dr. Lupo attended Duke University and earned his medical degree and internal medicine training from the University of Florida. Dr. Lupo completed Endocrinology training through a combined program at the University of California, San Diego and Scripps Clinic. Dr. Lupo is a Clinical Assistant Professor, Florida State University College of Medicine, a member of the Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the current Secretary of the Academy of Clinical Thyroidologists. Dr. Lupo lectures nationally and internationally on the topic of thyroid nodules and teaches neck ultrasound in the evaluation of nodules and cancer to other endocrinologists and surgeons. Dr. Lupo is also an active member of Mensa.

Ilaria Muller, MD PhD

Medico Ricercatore Specialista in Endocrinologia Milan, Italy

Ilaria Muller is Associate Professor of Endocrinology at the University of Milan and Consultant Endocrinologist at the Major Policlinico Hospital of Milan, Italy.

She obtained both Medical Degree and Specialization in Endocrinology at the University of Pisa (Italy), and then moved to Cardiff University (United Kingdom), where obtained a PhD in Molecular Endocrinology. After 6 years abroad, thanks to a fellowship awarded by the Italian Ministry of University and Research (Rita Levi Montalcini Brain Return Scheme), she moved back to Italy, in Milan.

Her main research topic is thyroid autoimmunity, with a “from bench to bedside” approach including basic, translational and clinical studies. She is currently investigating Graves’ disease and orbitopathy (including their immunological characterisation in connection with the microbiota), thyroid dysfunctions related to SARS-CoV-2 / Covid-19, the relationship between thyroid autoimmunity and breast cancer and thyroid disorders induced by immune reconstitution treatment (in particular alemtuzumab therapy for multiple sclerosis).

Daniel B. Rootman, MD

Doheny Eye Center UCLA Pasadena, CA

Dr. Rootman treats the entire spectrum of oculofacial plastic disorders including eyelid problems such as cancers, malpositions (turning in or turning out) and ptosis (drooping eyelids). He also specializes in scarless endoscopic tearing surgery and additionally applies these techniques for complicated orbital tumor removals. This complements his particular interest in orbital and complex skull base disease, such as thyroid orbitopathy, orbital vascular malformations and traumatic fractures. Dr. Rootman is also highly skilled in performing surgery and minimally invasive interventions for aesthetic enhancement.

Mario Salvi, MD

Graves' Orbitopathy Center Milan, Italy

Dr. Mario Salvi is a specialist in endocrinology and nuclear medicine and works at the Endocrinology Unit of the IRCCS Cà Granda Foundation, Ospedale Maggiore Policlinico and the Department of Clinical Sciences and Community of the University of Milan. He has an experience in the treatment of diseases like autoimmune thyroid diseases, Basedow’s disease – Graves, Basedowiana or endocrine orbitopathy, hypothyroidism and prelibial mixture.

Dr. Salvi treats patients with thyroid diseases (hyperthyroidism, hypothyroidism and goiter). In particular, he is specialized in the diagnosis and therapy of Graves (exophthalmos). He also deals with women’s endocrinology, managing thyroid diseases during pregnancy, polycystic ovary syndrome and menopausal-related diseases, including osteoporosis.

He carries out research in the field of autoimmune thyroid diseases at the University of Milan. He also taught endocrinology at the University of Parma and the McGill University of Montreal in Canada. He is a member of the endocrinology staff of the Policlinico of Milan and is the referent for the Basedowiana Orbitopathy.

Erin Shriver, MD, FACS

Carver College of Medicine Iowa City, IA

A California native, Erin Shriver, MD, FACS graduated from Pomona College and Stanford University School of Medicine. She completed her residency at the University of Iowa (2006) and spent the two years following residency completing an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellowship at the University of Miami Bascom Palmer Eye Institute. After fellowship, she joined the University of Miami faculty and established a full-time Oculoplastic service at Bascom Palmer’s Palm Beach office. Dr. Shriver practiced in Palm Beach for four years before returning to the University of Iowa in 2012.

Dr. Shriver is active in education and advocacy at the state, national, and international levels. She has received the American Academy of Ophthalmology Achievement and Secretariat Awards and was in their Leadership Development Program Class of 2017. Dr. Shriver is the ASOPRS Foundation Secretary, is the ASOPRS Alternate Delegate to the American Medical Association, and serves on the ASOPRS Education Committee. She is currently involved in advocacy at the state level through her role as President of the Iowa Academy of Ophthalmology. Dr. Shriver has also been involved in Women in Ophthalmology (WIO) since fellowship, chaired the WIO Summer Symposium in 2013, received the WIO Emerging Leader Award in 2015, and has served on the Board since 2014.

She enjoys sharing her passion for oculoplastics with colleagues and trainees and has received numerous teaching awards including the Department of Ophthalmology Medical Student Teaching Award in 2015 and 2017 and the Resident Teaching Award 2018. Her research interests are varied including: advances in oculoplastic techniques, critical analysis of current oculoplastic practices, establishing novel metrics for eyelid position and periocular aesthetics, surgical simulation training, the physics of eyelid malposition, and intimate partner violence in the ophthalmic patient population.

She has recently become interested in advocating for social change through ophthalmology and chaired Women in Ophthalmology sponsored panels at the 2018 World Ophthalmology Congress in Barcelona entitled Ophthalmologists for Social Change and Looking Beyond Clinical Care – Making a Global Impact. She also created the Champion for Change Awards which were presented to men and women who have promoted diversity and inclusion within the field of ophthalmology.

When she is not working, she enjoys exercising and spending time with her husband, two young sons, and golden retriever. She credits much of her success to her supportive family, in particular her devoted husband, David Shriver.

Naykky Singh Ospina, MD

University of Florida Gainesville, FL

Dr. Singh Ospina is an Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at the University of Florida. She is board certified in Internal Medicine. She was awarded her medical degree from the University of Panama, Panama. She completed her Internal Medicine residency at the John H. Stroger, Jr. Hospital of Cook County.  She received her Endocrinology, Diabetes and Metabolism fellowship training at the Mayo Clinic, Rochester where she also completed a Master in Clinical and Translational Science.

Terry J. Smith, MD

University of Michigan Kellogg Eye Center Ann Arbor, MI

Dr. Terry J. Smith, the Frederick G.L. Huetwell Professor Emeritus in Ophthalmology and Visual Sciences at the University of Michigan, is an internationally-known endocrinologist who has studied Graves’ disease, its eye manifestations, and related autoimmune disease for over 20 years. Dr. Smith’s laboratory was first to describe the unique molecular attributes of tissue surrounding the eye that make it susceptible to inflammation in Graves’ disease. He has identified a novel autoantibody that binds to and activates a specific receptor, resulting in an exaggerated autoimmune response. His investigation of these mechanisms has yielded several potential therapeutic targets that may interrupt the disease process. These will provide the focus for future clinical trials. Dr. Smith received his medical degree from the University of Missouri School of Medicine and completed his residency at the University of Illinois in Chicago and Sinai Hospital in Baltimore. He has completed fellowships in biophysics at the University of California School of Medicine, San Francisco, in molecular biochemistry at Columbia University in New York, and clinical endocrinology at the Pritzker School of Medicine, University of Chicago. Dr. Smith is the author of over 275 articles and book chapters, and has been awarded five patents for his research discoveries. He has been elected to the Orbit Society, is chief scientific officer for the National Graves’ Foundation, and serves as reviewer for numerous scientific journals. Dr. Smith has been funded continuously by the National Institutes of Health and the Veterans Administration since 1983.

Diego Strianese MD, PhD

University of Naples Federico II Naples, Italy

Diego Strianese practices in Naples, Italy. Strianese and is highly rated in 7 conditions, according to our data. His top areas of expertise are Thyroid Eye Disease, Lacrimal Gland Tumor, Graves Disease, Cerebral Cavernous Malformation, and Vitrectomy.

His clinical research consists of co-authoring 55 peer reviewed articles in the past 15 years.

Prem Subramanian, MD, PhD

University of Colorado School of Medicine Denver, CO

Professor Timothy Sullivan

Northside Eye Specialists Queensland, Australia

Professor Timothy Sullivan completed his Ophthalmology training in 1988, then undertook further subspecialty Fellowship Training in Oculoplastics, Eyelid, Lacrimal and Orbital Disease at Moorfields Eye Hospital, London and Paediatric Ophthalmology in Toronto at The Hospital for Sick Children.

When he returned to Brisbane in 1992 he joined Northside Eye Specialists, to provide tertiary and quaternary level subspecialty care. Since then he has also worked in the public sector, conducting the Orbital Clinic at the Royal Brisbane and Women’s Hospital and the Queensland Children’s Hospital.

While focusing on clinical care, he has always conducted clinical research to be abreast of and push latest developments. He has published over 130 papers in peer reviewed journals, book chapters and 400 presentations at National and International meetings. He is on the editorial boards of Clinical Experimental Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery and the Asia Pacific Journal of Ophthalmology.

Complementing his clinical and research efforts he is involved in medical student, registrar and Fellow teaching as Professor of Ophthalmology for the University of Queensland. He is a former President of the Australian and New Zealand Society of Ophthalmic Plastic Surgery and the Asia-Pacific Society of Ophthalmic Plastic and Reconstructive Surgery, and an active Fellow of the American and European Societies of Oculoplastic and Reconstructive Surgery. He is on the board of the International Thyroid Eye Disease Society. With this academic background, he continues to provide first class care to his patients.

Lilly Wagner, MD

Mayo Clinic Rochester, MN

Lilly H. Wagner, M.D., is a board certified ophthalmologist and oculoplastic surgeon with ASOPRS accredited fellowship training in plastic and reconstructive surgery of the eyelids, orbit and lacrimal system. Using her detailed knowledge of the connection between eyelid anatomy and eye health, she works closely with patients to understand their individual concerns and goals. Some of the most common conditions that Dr. Wagner evaluates and treats are:

Skin cancer of the eyelids requiring reconstruction after excision with Mohs surgery
Droopy eyelids or brows that affect vision or cause undesirable cosmetic appearance
Excess watering or infections that are caused by blockage of the tear drain system
Dr. Wagner is passionate about establishing multidisciplinary care models. Through collaboration with colleagues in plastic surgery, otorhinolaryngology, dermatology and endocrinology, she offers customized treatment approaches for patients with complex and advanced conditions affecting the ocular adnexa, skull base and midface. The cases that Dr. Wagner manages together with consultants from other specialties include:

Thyroid eye disease (TED) in the dedicated TED clinic
Tumors of the sinus cavities or skull base with extension into the orbit
Facial skin cancers with extension onto the eyelids
Revision of prior surgery for facial trauma or cosmetic facial and eyelid surgery